Natren Inc.

Form 483 issued October 8, 2019 · Westlake Village, California

Inspection
Oct 3 – Oct 8, 2019
Investigator
Taichun Qin
Observations
2
Pages
3
FEI number
2024261

In short: On October 8, 2019, FDA issued a Form 483 with 2 observations to Natren Inc. in Westlake Village, California (FEI 2024261) after an inspection that ran Oct 3 – Oct 8, 2019. The investigator was Taichun Qin. Most observations concern laboratory controls and production; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Laboratory controls and production account for 2 of 2 observations.

Laboratory controls1
Production1

Most cited: 21 CFR 211.160(a) (1×) · 211.100(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Established laboratory control mechanisms are not documented at…

  2. 02

    Deviations from written production and process control procedures are…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Natren Inc.?

FDA listed 2 observations on this Form 483, mostly about laboratory controls and production. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Natren Inc.?

Taichun Qin is named on this Form 483, for the inspection of Oct 3 – Oct 8, 2019. Each investigator has a profile showing what they cite most.

When was Natren Inc. inspected by FDA?

The inspection ran Oct 3 – Oct 8, 2019, and the Form 483 is dated October 8, 2019.

How do I get the full Form 483 for Natren Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free